A Fatal Complication of A Peripheral Venous Catheter


Peripheral venous catheters (PVC) are widely used in the hospital and seem to be innocent. However, complications can be devastating. We present a case of a fatal septic shock due to vertebral osteomyelitis after PVC-related Staphylococcus aureus bacteremia (SAB). Staphylococcus aureus is a leading cause of bacteraemia in both the community and the hospital with a significantly increased incidence over the last several decades. Intravascular catheters are the most common cause of SAB. Morbidity and mortality are high, even with appropriate therapy. Although complications are known and common, they may be difficult to recognize. Vertebral osteomyelitis is one of these known severe complications.

Share and Cite:

L. Haas, B. Kortlandt, S. Thijsen, J. Fijen and S. Sankatsing, "A Fatal Complication of A Peripheral Venous Catheter," International Journal of Clinical Medicine, Vol. 3 No. 5, 2012, pp. 433-437. doi: 10.4236/ijcm.2012.35081.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Jacobsson G, Dashti S, Wahlberg T, Andersson R, “The epide-miology of and risk factors for invasive Staphylococcus aureus infections in western Sweden,” Scand J Infect Dis, Vol. 39, 2007, pp. 6-13. doi:10.1080/00365540600810026
[2] Moreillon P, Que YA, Glauser MP, “Staphylococcus aureus (including staphylococcal toxic shock),“ In: G.L. Mandell, J.E. Bennett, R. Dolin, Ed., Principles and Practice of Infectious Diseases. 6th edition. Philadelphia, Churchill Livingstone, 2005, pp.2321.
[3] Jensen AG, Wachmann CH, Poulsen KB, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N, “Risk factors for hospital-acquired Staphylococcus aureus bacteremia,” Arch Intern Med, Vol. 159, 1999, pp. 1437-44. doi:10.1001/archinte.159.13.1437
[4] Skinnner D, Keefer CS, “Significance of bacteremia caused by Staphylococcus aureus: A study of one hundred and twenty-two cases and a review of the literature concerned with experimental infection in animals,” Arch Intern Med, Vol. 68, 1941, pp. 851-75. doi:10.1001/archinte.1941.00200110003001
[5] Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH, “Health-care-associated bloodstream infection: A distinct entity? Insights from a large U.S. database,” Crit Care Med, Vol. 34, 2006, pp.2588-95. doi:10.1097/01.CCM.0000239121.09533.09
[6] Lautenschlager S, Herzog C, Zimmerli W, “Course and outcome of bacteremia due to Staphyloccus aureus: evaluation of different clinical case definitions,” Clin Infect Dis, Vol. 16, 1993, pp. 567-73. doi:10.1093/clind/16.4.567
[7] van Hal SJ, Jensen SO, Vaska VL, Espidido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev, Vol. 25, 2012, pp. 362-86. doi:10.1128/CMR.05022-11
[8] Khatib R, Johnson LB, Fakih MG, Riederer K, Khosrovaneh A, Shamse Tabriz M, Sharma M, Saeed S, “Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome,“ Scand J Infect Dis, Vol. 38, pp. 7–14. doi:10.1080/00365540500372846
[9] Zimmerli W, “Clinical practice. Vertebral osteomyelitis,” N Engl J Med, Vol. 362, 2010, pp. 1022-9. doi:10.1056/NEJMcp0910753
[10] Vos FJ, Bleeker-Rovers CP, Sturm PD, Krabbe PF, van Dijk AP, Cuijpers ML, Adang EM, Wanten GJ, Kullberg BJ, Oyen WJ, “18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia,” J Nucl Med, Vol. 51, pp.1234-40. doi:10.2967/jnumed.109.072371
[11] Cheung WY, Luk KD. Pyogenic spondylitis. Int Orthop, Vol 36, 2012, pp. 397-404. doi:10.1007/s00264-011-1384-6
[12] Sapico FL, Montgomerie JZ, “Vertebral osteomyelitis,” Infect Dis Clin North Am, Vol. 4, 1990, pp. 539-50.
[13] Lew DP, Waldvogel FA, ”Osteomyelitis,” Lancet, Vol. 364, 2004, pp. 369-79. doi:10.1016/S0140-6736(04)16727-5
[14] [14] Torda AJ, Got-tlieb T, Bradbury R, ”Pyogenic vertebral osteomyelitis: analysis of 20 cases and review,” Clin Infect Dis, Vol. 20, 1995, pp. 320-8. doi:10.1093/clinids/20.2.320
[15] Patzakis MJ, Rao S, Wilkins J, Moore TM, Harvey PJ, “Analysis of 61 cases vertebral osteomyelitis,” Clin Orthop Relat Res, Vol. 264, 1991, pp. 178-83.
[16] Ohtori S, Suzuki M, Koshi T, Yamashita M, Yamauchi K, Inoue G, Orita S, Eguchi Y, Kuniyoshi K, Ochiai N, Kishida S, Takaso M, Aoki Y, Ishikawa T, Arai G, Miyagi M, Kamoda H, Suzuki M, Nakamura J, Toyone T, Takahashi K, “18F-fluorodeoxyglucose-PET for patients with suspected spondylitis showing Modic change,” Spine, Vol. 35, 2010, pp. E1599-603. doi:10.1097/BRS.0b013e3181d254b4
[17] Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK, “Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America,” Clin Infect Dis, Vol. 49, 2009, pp. 1–45. doi:10.1086/599376
[18] Landman GWD, Bouwhuis JW, Bloembergen P, van de Meer JTM, Groeneveld PHP, “Evaluation of diagnosis and therapy of Staphylococcus aureus bacteraemia: recommended minimum treatment duration of 2 weeks not always met. [Evaluatie van de diagnostiek en behandeling van bacteri?mie door Staphylococcus aureus. Minimale behan-delduur van 2 weken vaak niet gehaald],” Ned Tijdschr Geneesk, Vol. 155, 2011, pp. 1690-1695.
[19] Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ, “Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteraemia,” Clin Infect Dis, Vol. 46, 2008, pp. 1000–1008. doi:10.1086/529190

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.